Arrowhead Pharmaceuticals (ARWR) FCF Margin Growth (1y) (2011 - 2026)
Arrowhead Pharmaceuticals (ARWR) FCF Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arrowhead Pharmaceuticals | 11.98 Bn | 10.18 Bn | - | 2,816.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,816.00 |
| Dec 31, 2025 | 595,813.00 |
| Dec 31, 2024 | -70,191.00 |
| Dec 31, 2023 | -506,898.00 |
| Sep 30, 2023 | -84,066.00 |
| Jun 30, 2023 | 43,020.00 |
| Mar 31, 2023 | -7,852.00 |
| Dec 31, 2022 | 6,154.00 |
| Sep 30, 2022 | -23,711.00 |
| Jun 30, 2022 | -16,865.00 |
| Mar 31, 2022 | -74,419.00 |
| Dec 31, 2021 | -4,174.00 |
| Sep 30, 2021 | 8,803.00 |
| Jun 30, 2021 | 5,682.00 |
| Mar 31, 2021 | 91,496.00 |
| Dec 31, 2020 | -10,820.00 |
| Jun 30, 2020 | -25,346.00 |
| Mar 31, 2020 | -31,101.00 |
| Dec 31, 2019 | -57,798.00 |
| Jun 30, 2019 | 213,176.00 |